<DOC>
	<DOCNO>NCT01188811</DOCNO>
	<brief_summary>The purpose study determine lipoic acid protect brain slow disability secondary progressive multiple sclerosis .</brief_summary>
	<brief_title>Lipoic Acid Secondary Progressive Multiple Sclerosis ( MS )</brief_title>
	<detailed_description>There approve medication neuroprotective able slow disability accumulation secondary progressive multiple sclerosis ( SPMS ) . This two-year study determine daily oral intake lipoic acid , natural supplement , prove superior placebo reduce injury brain reduce disability progression SPMS . Neuroprotection measure extent brain volume loss see MRI , disability measure neurological status quality life .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Chronic Progressive</mesh_term>
	<mesh_term>Thioctic Acid</mesh_term>
	<criteria>Diagnosis SPMS Age 4070 year Able understand English able give inform consent Unable undergo MRI test For ambulatory subject , selfreported medical neurological condition MS cause progressive fluctuating problem affect walk ( e.g . worsen neuropathy , uncontrolled low extremity arthritis , uncontrolled heart lung disease ) For ambulatory subject , fix and/or stable condition le 1 year duration affect walking ( e.g . joint replacement , lumbar stenosis , alcoholism , stroke , etc . ) Pregnant breastfeeding . Current major disease disorder MS ( cancer , kidney , heart lung disease , posttraumatic stress disorder ) may interfere study procedure Natalizumab , mitoxantrone , azathioprine take last 12 month Other immunosuppressant chemotherapy take last 12 month Scheduled ( every 3 month frequently ) IV steroid use last 12 month IV oral steroid take past 60 day . Lipoic acid take past 60 day . Subject insulindependent diabetes control oral diabetes medication</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Multiple Sclerosis</keyword>
	<keyword>Multiple sclerosis , chronic progressive</keyword>
	<keyword>Neuroprotective agent</keyword>
	<keyword>Magnetic resonance imaging</keyword>
	<keyword>Optical coherence tomography</keyword>
	<keyword>Gait</keyword>
	<keyword>Thioctic acid</keyword>
	<keyword>Alpha-lipoic acid</keyword>
</DOC>